AIFA — authorised 9 December 2022
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
🇮🇹 Locametz in Italy
AIFA authorised Locametz on 9 December 2022
Marketing authorisation
Locametz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Italy
Frequently asked questions
Is Locametz approved in Italy?
Yes. AIFA authorised it on 9 December 2022.
Who is the marketing authorisation holder for Locametz in Italy?
NOVARTIS EUROPHARM LIMITED holds the Italian marketing authorisation.